PFIZER INC Shareholders' Equity
PFIZER INC (PFE) had Shareholders' Equity of $85.19 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-28: Stockholders' Equity Attributable to Parent $85.19B.
- 2026-03-29: Stockholders' Equity Attributable to Parent $90.10B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $86.48B.
- 2025-09-28: Stockholders' Equity Attributable to Parent $92.80B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-28 | $85.19B 10-Q · filed 2026-08-04 |
| 2026-03-29 | $90.10B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $86.48B 10-Q · filed 2026-08-04 |
| 2025-09-28 | $92.80B 10-Q · filed 2025-11-04 |
| 2025-06-29 | $88.69B 10-Q · filed 2025-08-05 |
| 2025-03-30 | $90.34B 10-Q · filed 2025-05-05 |
| 2024-12-31 | $88.20B 10-K · filed 2026-02-26 |
| 2024-09-29 | $92.29B 10-Q · filed 2024-11-04 |
| 2024-06-30 | $87.70B 10-Q · filed 2024-08-05 |
| 2024-03-31 | $92.28B 10-Q · filed 2024-05-08 |
| 2023-12-31 | $89.01B 10-K · filed 2025-02-27 |
| 2023-10-01 | $96.93B 10-Q · filed 2023-11-08 |
| 2023-07-02 | $99.02B 10-Q · filed 2023-08-09 |
| 2023-04-02 | $100.97B 10-Q · filed 2023-05-10 |
| 2022-12-31 | $95.66B 10-K · filed 2024-02-22 |
| 2022-10-02 | $92.63B 10-Q · filed 2022-11-09 |
| 2022-07-03 | $87.21B 10-Q · filed 2022-08-10 |
| 2022-04-03 | $82.42B 10-Q · filed 2022-05-11 |
| 2021-12-31 | $77.20B 10-K · filed 2023-02-23 |
| 2021-10-03 | $75.69B 10-Q · filed 2021-11-12 |
| 2021-07-04 | $70.04B 10-Q · filed 2021-08-12 |
| 2021-04-04 | $68.62B 10-Q · filed 2021-05-13 |
| 2020-12-31 | $63.24B 10-K · filed 2022-02-24 |
| 2020-09-27 | $65.26B 10-Q · filed 2020-11-05 |
| 2020-06-28 | $64.34B 10-Q · filed 2020-08-06 |
| 2020-03-29 | $65.03B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $63.14B 10-K · filed 2021-02-25 |
| 2019-09-29 | $65.10B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $59.57B 10-Q · filed 2019-08-08 |
| 2019-03-31 | $58.81B 10-Q · filed 2019-05-09 |
| 2018-12-31 | $63.41B 10-K · filed 2020-02-27 |
| 2018-09-30 | $71.32B 10-Q · filed 2018-11-08 |
| 2018-07-01 | $69.78B 10-Q · filed 2018-08-09 |
| 2018-04-01 | $70.18B 10-Q · filed 2018-05-10 |
| 2017-12-31 | $71.31B 10-K · filed 2019-02-28 |
| 2017-10-01 | $60.77B 10-Q · filed 2017-11-09 |
| 2017-07-02 | $58.37B 10-Q · filed 2017-08-10 |
| 2017-04-02 | $58.44B 10-Q · filed 2017-05-11 |
| 2016-12-31 | $59.54B 10-K · filed 2018-02-22 |
| 2016-10-02 | $63.31B 10-Q · filed 2016-11-10 |
| 2016-07-03 | $62.77B 10-Q · filed 2016-08-11 |
| 2016-04-03 | $63.07B 10-Q · filed 2016-05-12 |
| 2015-12-31 | $64.72B 10-K · filed 2017-02-23 |
| 2015-09-27 | $66.84B 10-Q · filed 2015-11-05 |
| 2015-06-28 | $66.89B 10-Q · filed 2015-08-06 |
| 2015-03-29 | $67.30B 10-Q · filed 2015-05-07 |
| 2014-12-31 | $71.30B 10-K · filed 2016-02-29 |
| 2014-09-28 | $77.99B 10-Q · filed 2014-11-06 |
| 2014-06-29 | $76.63B 10-Q · filed 2014-08-07 |
| 2014-03-30 | $77.77B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $76.31B 10-K · filed 2015-02-27 |
| 2013-09-29 | $77.97B 10-Q · filed 2013-11-08 |
| 2013-06-30 | $78.55B 10-Q · filed 2013-08-09 |
| 2013-03-31 | $82.25B 10-Q · filed 2013-05-10 |
| 2012-12-31 | $81.26B 10-K · filed 2014-02-28 |
| 2012-09-30 | $81.70B 10-Q · filed 2012-11-09 |
| 2012-07-01 | $79.55B 10-Q · filed 2012-08-09 |
| 2012-04-01 | $83.26B 10-Q · filed 2012-05-10 |
| 2011-12-31 | $82.19B 10-K · filed 2013-02-28 |
| 2011-10-02 | $90.05B 10-Q · filed 2011-11-10 |
| 2011-07-03 | $88.48B 10-Q · filed 2011-08-11 |
| 2011-04-03 | $90.07B 10-Q · filed 2011-05-12 |
| 2010-12-31 | $87.81B 10-K · filed 2012-02-28 |
| 2010-10-03 | $87.64B 10-Q · filed 2010-11-12 |
| 2010-07-04 | $86.44B 10-Q · filed 2010-08-12 |
| 2010-04-04 | $89.66B 10-Q · filed 2010-05-13 |
| 2009-12-31 | $90.01B 10-K · filed 2011-02-28 |
| 2009-09-27 | $66.16B 10-Q · filed 2009-11-05 |
| 2009-06-28 | $63.04B 10-Q · filed 2009-08-06 |
| 2008-12-31 | $57.56B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |